<?xml version="1.0" encoding="utf-8"?> 

<rss version="2.0"> 

<channel>

<title>LexisNexis&#174; Mealey's&#8482; Diet Drugs Legal News</title>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

<description>Headline Diet Drugs Legal News from LexisNexis&#174;</description>

<language>en-us</language>

<image>

<title>LexisNexis&#174; Headline Diet Drugs Legal News</title>

<url>http://www.lexisnexis.com/mealeys/images/lexismealeyslogo.gif</url>

<width>130</width> 
  
<height>29</height>

<link>http://www.lexisnexis.com/mealeys/news.aspx</link>

</image> 

<copyright>Copyright 2011</copyright>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-9 Mealeys Diet Drug Report 1%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>4th Fen-Phen Lawyer Disbarred For Role In Cheating Kentucky Clients</title>
<description>
<![CDATA[FRANKFORT, Ky. - A fourth Kentucky plaintiff attorney was disbarred for life by the Commonwealth's Supreme Court on Sept. 22 for his role in a scheme to defraud 440 of his firm's clients out of $55 million from a settlement over the diet drugs Pondimin and Redux (Kentucky Bar Association v. David L. Helmers, No. 2011-SC-106-KB, Ky. Sup.; 2011 Ky. LEXIS 126; See July 2010, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-9 Mealey's Diet Drug Report 1 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-9 Mealeys Diet Drug Report 2%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>3rd Circuit Affirms Denial Of Compensation To Fen-Phen Claimant</title>
<description>
<![CDATA[PHILADELPHIA - Saying the record supported a finding either for a former fen-phen user's $545,310 claim or against it, the Third Circuit U.S. Court of Appeals on Sept. 20 said the trial judge had committed no abuse of discretion and affirmed the trial court's denial of benefits (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, Donna Pickering, appellant, No. 10-3848, 3rd Cir., MDL Docket No. 1203, 2:99-cv-20593, E.D. Pa.; 2011 U.S. App. LEXIS 19350; See September 2010, Page 12). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-9 Mealey's Diet Drug Report 2 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-9 Mealeys Diet Drug Report 3%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Woman Seeks To Withdraw Appeal Of Benefit Reduction</title>
<description>
<![CDATA[PHILADELPHIA - A woman claiming that Wyeth's diet drugs damaged her heart's aortic valve asked on Oct. 3 to withdraw her appeal to the Third Circuit U.S. Court of Appeals of the settlement trust's reduction of her claim based on the presence of aortic sclerosis, less than a month after she filed it (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, Hazel J. Morehouse v. AHP Settlement Trust, No. 11-3446, 3rd Cir.; MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; See September 2011, Page 7). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-9 Mealey's Diet Drug Report 3 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-9 Mealeys Diet Drug Report 4%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>10th Circuit Upholds Arbitrator's $8M Award To Fen-Phen Attorney</title>
<description>
<![CDATA[DENVER - A fen-phen attorney seeking to overturn an $8 million arbitration award in favor of another attorney with whom he had a shared representation agreement has not raised issues that justify overturning the award, the 10th Circuit U.S. Court of Appeals ruled Sept. 21 (Charles F. Abbott, et al. v. Law Office of Patrick J. Mulligan, et al., No. 10-4113, 10th Cir.; 2011 U.S. App. LEXIS 19468; See July 2010, Page 14). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-9 Mealey's Diet Drug Report 4 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-9 Mealeys Diet Drug Report 5%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Judge: Woman Charged With Fraud May Not Offer Psychiatric Testimony</title>
<description>
<![CDATA[PHILADELPHIA - A mentally ill woman charged with fraud stemming from the alleged submission of multiple claims with the American Home Products (AHP) national fen-phen settlement may not present psychiatric testimony to show that her illness prevented her from forming criminal intent, a Pennsylvania federal judge ruled Sept. 8 (USA v. Dee Lynn Andrews, No. 09-261, E.D. Pa.; 2011 U.S. Dist. LEXIS 101467). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-9 Mealey's Diet Drug Report 5 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-9 Mealeys Diet Drug Report 6%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Companies Claim Favorable Results For Diet Drug Combinations</title>
<description>
<![CDATA[ORLANDO, Fla. - Two companies are claiming favorable, albeit non-peer-reviewed, results for experimental weight-loss combination therapies at "Obesity 2011," the 29th annual meeting of The Obesity Society in Orlando. 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-9 Mealey's Diet Drug Report 6 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-8 Mealeys Diet Drug Report 1%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Putative Class Alleging Dexatrim Contamination Dismissed For Lack Of Loss</title>
<description>
<![CDATA[INDIANAPOLIS - A putative economic class action alleging the presence of dangerous amounts of hexavalent chromium in Chattem Inc.'s diet supplement Dexatrim Max failed to demonstrate any injury or economic loss, an Indiana federal judge said Aug. 31 in dismissing the claims (Lee Hughes and Elizabeth Leftwich v. Chattem Inc., No. 1:10-1407, S.D. Indiana, Indianapolis Div.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-8 Mealey's Diet Drug Report 1 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-8 Mealeys Diet Drug Report 2%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Judge Says Plaintiffs Have Shown Jurisdiction Over Canadian Company</title>
<description>
<![CDATA[SAN DIEGO - Plaintiffs have made out a prima facie case for personal jurisdiction over a Canadian company based on control and alter-ego theories, the judge supervising multidistrict litigation over Iovate Health Sciences Group's Hydroxycut products said in an Aug. 29 opinion (In Re: Hydroxycut Marketing and Sales Practices Litigation, MDL No. 2087; See July 2011, Page 8). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-8 Mealey's Diet Drug Report 2 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-8 Mealeys Diet Drug Report 3%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Woman Whose Benefits Were Reduced By Trust Appeals To 3rd Circuit</title>
<description>
<![CDATA[PHILADELPHIA - A woman claiming Wyeth's diet drugs damaged her heart's aortic valve appealed the Settlement Trust's reduction of her claim based on the presence of aortic sclerosis to the Third Circuit U.S. Court of Appeals on Sept. 6 (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-8 Mealey's Diet Drug Report 3 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-8 Mealeys Diet Drug Report 4%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Cites Mitral Valve Prolapse In Reduction Of Benefits</title>
<description>
<![CDATA[PHILADELPHIA - Mitral valve prolapse with ruptured chordae tendinae justified reduction of a diet drug settlement claim potentially worth $297,962 to approximately 20 percent of that value, the fen-phen multidistrict litigation judge said Aug. 8 (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-8 Mealey's Diet Drug Report 4 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-8 Mealeys Diet Drug Report 5%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Says Substandard Echocardiogram Does Not Support Mitral Claim</title>
<description>
<![CDATA[PHILADELPHIA - The echocardiogram study submitted by a claimant in support of a mitral valve claim potentially worth $528,405 in the settlement contains insufficient useful information but what little it does show does not support a claim of moderate mitral regurgitation, the fen-phen multidistrict litigation judge said Aug. 15 (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; 2011 U.S. Dist. LEXIS 90718). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-8 Mealey's Diet Drug Report 5 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-8 Mealeys Diet Drug Report 6%20(2011)%20%22&amp;pageLimit=10&amp;pageNumber=0&amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;relativeDateValue=NONE&amp;fromDate=&amp;toDate=&amp;loc=mealeysrss</link>
<title>Law Firm Petitions For $246,000 Fee In $1.2 Million Award</title>
<description>
<![CDATA[PHILADELPHIA - Saying it has worked for nearly a decade to win more than $1.2 million in Matrix benefits for a woman's estate, a California plaintiff firm on Sept. 7 petitioned the fen-phen multidistrict litigation and settlement court for a fee of more than $246,000 (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; See February 2011, Page 8). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;keyenum=25271&amp;keytnum=0&amp;searchtype=get&amp;search=4-8 Mealey's Diet Drug Report 6 (2011)&amp;view=full&amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>

<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 1%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Wellnx Settles Consumer Litigation Over Diet Supplements</title>
<description>
<![CDATA[BOSTON - Citing the risks of protracted litigation and the small recoveries likely to individual plaintiffs, the parties in litigation over Wellnx's diet supplements such as Slimquick and Liquid Hoodia in the U.S. District Court for the District of Massachusetts on Aug. 3 announced an opt-out class settlement that offers a maximum refund of $28 per class member and attorney fees of $1,725,000 (In re: Wellnx Marketing and Sales Practices Litigation, MDL No. 1861, D. Mass.; See July 2011, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 1 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 2%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Rules Echocardiogram Supports $628,632 Heart Valve Claim</title>
<description>
<![CDATA[PHILADELPHIA - A woman asserting a claim of heart-valve injury worth $628,632 against the national diet drug settlement has demonstrated compensable injury, the Pennsylvania federal judge supervising the American Home Products (AHP) national diet drug settlement said in a July 19 opinion (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; 2011 U.S. Dist. LEXIS 79025). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 2 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 3%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Aortic Sclerosis Diagnosis Reduces Settlement Benefit, Fen-Phen Judge Rules</title>
<description>
<![CDATA[PHILADELPHIA - The Pennsylvania federal judge supervising the American Home Products national diet drug settlement has affirmed the trust's reduction of $415,893 in settlement benefits to about 20 percent of that amount, saying in a July 20 opinion that the claimant had not rebutted a diagnosis of aortic sclerosis, a reduction factor in the settlement (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation], MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 3 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 4%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Orders Trust To Pay $512,025 Injury Claim</title>
<description>
<![CDATA[PHILADELPHIA - The Pennsylvania federal judge supervising the American Home Products national diet drug settlement overruled the settlement trust's denial of a claim worth $512,025, saying in a July 20 opinion that the claimant had demonstrated compensable injury and the trust's denial was done "without adequate support" (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation], MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 4 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 5%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Reverses Trust, Orders $496,153 Claim To Be Paid</title>
<description>
<![CDATA[PHILADELPHIA - The Pennsylvania federal judge supervising the American Home Products national diet drug settlement ordered the trust to pay a claim worth $496,153, saying July 19 that the claimant had demonstrated moderate mitral regurgitation and an abnormal left atrial dimension as defined by the Settlement Agreement (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; 2011 U.S. Dist. LEXIS 79037). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 5 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 6%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Heart Surgery Claimant Says Trust Influences Auditing Cardiologist</title>
<description>
<![CDATA[PHILADELPHIA - A woman asserting a claim for heart valve surgery against the American Home Products national diet drug settlement says the settlement trust's justifications for refusing to disclose communications with an auditing cardiologist whose report reduced the value of her claim by 80 percent demonstrates that it is in an improper adversarial position with the claimant and suggests collusion with the supposedly independent auditor (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; See June 2011, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 6 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 7%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Trust Says Claimant Seeks To Conceal Relevant Documentation</title>
<description>
<![CDATA[PHILADELPHIA - The trust that administers the American Home Products national diet drug settlement says in a June 15 brief in the U.S. District Court for the Eastern District of Pennsylvania that a claimant against the settlement may be concealing unfavorable medical records to obtain additional compensation (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 7 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 8%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Rules Compensation Is Reduced By Previous Injury Award</title>
<description>
<![CDATA[PHILADELPHIA - A claimant who obtained more than $900,000 from the American Home Products national diet drug settlement may not opt out and sue Wyeth for disease progression or obtain additional compensation through the settlement, the Pennsylvania federal judge supervising the settlement said July 20 (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; 2011 U.S. Dist. LEXIS 79377). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 8 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 9%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Stroke Victim Argues Later Echocardiograms Can't Reduce Benefits</title>
<description>
<![CDATA[PHILADELPHIA - A stroke victim seeking additional compensation under the American Home Products national diet drug settlement says in a July 21 reply brief that only the original, pre-January 2003 Screening Period echocardiogram that qualified a claimant for benefits can be invoked by the settlement trust to assert a reduction factor because of a confounding medical condition (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.; See July 2011, Page 6). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 9 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 10%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Fen-Phen Judge Rules Echocardiogram Does Not Show Compensable Injury</title>
<description>
<![CDATA[PHILADELPHIA - A claimant against the American Home Products national diet drug settlement has not demonstrated moderate regurgitation in the mitral valve, the Pennsylvania federal judge supervising the settlement said Aug. 8, denying a claim potentially worth $486,424 (In Re: Diet Drugs [Phentermine/Fenfluramine/Dexfenfluramine] Products Liability Litigation, MDL Docket No. 1203, Sheila Brown, et al. v. American Home Products Corp., No. 99-20593, E.D. Pa.). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 10 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 11%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Judge: Warranty Claims Lack Privity; Fraud Claims Lack Particularity</title>
<description>
<![CDATA[SAN DIEGO - The judge supervising multidistrict litigation over Hydroxycut weight-loss supplements dismissed three counts from a lawsuit asserting injury from the use of the products, saying July 21 that the plaintiff failed to allege privity in his warranty claims and to provide the particulars necessary to sustain a claim of fraud (In Re: Hydroxycut Marketing and Sales Practices Litigation, MDL No. 2087, Steve E. Snow v. Iovate Health Sciences USA Inc., No. 10cv1485, S.D. Calif.; See August 2010, Page 10). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 11 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 12%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Long-Running Case Asserting Wrongful Death Settles In Ohio Federal Court</title>
<description>
<![CDATA[CINCINNATI - A lawsuit alleging that Wyeth's diet drug Redux caused a woman's death from primary pulmonary hypertension (PPH) has settled, according to an order filed July 26 in U.S. District Court for the Northern District of Ohio (Romonia Longs v. Wyeth, No. 1:03 CV 2042, N.D. Ohio, Eastern Div.; See April 2011, Page 5). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 12 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 13%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Texas Appeals Court Says Plaintiffs Have No Control Over Distribution Of Fees</title>
<description>
<![CDATA[DALLAS - A long-running dispute between former diet drug users and an attorney with whom they had not contracted was again resolved in favor of the attorney on July 14; the Fifth District Texas Court of Appeals decided that the plaintiffs had no say in how attorneys divided a contingent fee to which plaintiffs had agreed (Janeen A. Bailey, et al. v. Michael T. Gallagher, John H. Kim, and Gallagher, Lewis, Downey &amp;amp; Kim, No. 05-09-00868-CV, Texas App., 5th District; Tex. App. LEXIS 5383). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 13 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>
 
<item>
<link>http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-7 Mealeys Diet Drug Report 14%20(2011)%20%22&amp;amp;pageLimit=10&amp;amp;pageNumber=0&amp;amp;publication=All+Mealey+Publications%3BMEALEY%3BMEALEY&amp;amp;relativeDateValue=NONE&amp;amp;fromDate=&amp;amp;toDate=&amp;amp;loc=mealeysrss</link>
<title>Redline Maker Says Putative Class Fails To Meet Requirements</title>
<description>
<![CDATA[SAN DIEGO - Vital Pharmaceuticals Inc. says in a July 11 response that the plaintiff in a putative class action over the company's Redline diet supplements has failed to meet any of the four requirements for class certification of Federal Rule of Civil Procedure 23 - commonality, typicality, adequacy of representation and superiority of class handling - and seeks to represent even satisfied customers of the products (Zack Aaronson, et al. v. Vital Pharmaceuticals Inc., No. 3:09-cv-1333, S.D. Calif.; See June 2011, Page 8). 
<a href="http://www.lexis.com/research/xlink?canceldest=form&amp;amp;keyenum=25271&amp;amp;keytnum=0&amp;amp;searchtype=get&amp;amp;search=4-7 Mealey's Diet Drug Report 14 (2011)&amp;amp;view=full&amp;amp;ORIGINATION_CODE=00144" target="_blank">Full story on lexis.com</a>]]>
</description>
</item>

</channel>

</rss> 

